Summary & Overview
HCPCS G0121: Colonoscopy for Average-Risk Colorectal Cancer Screening
HCPCS Level II code G0121 designates a screening colonoscopy for individuals who do not meet high-risk criteria for colorectal cancer. As a preventive screening code, it is widely used across outpatient endoscopy centers and hospital outpatient departments and plays a central role in national colorectal cancer screening efforts and quality measurement programs. Coverage and billing practices for G0121 affect access to preventive care, patient cost sharing, and population-level screening rates.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage approaches, coding and billing context, and common operational considerations for submitting G0121 claims. The publication also summarizes relevant benchmarking metrics, policy updates affecting preventive colonoscopy reimbursement and coverage, and clinical context distinguishing average-risk screening from diagnostic or high-risk procedures.
This resource is intended to inform billing professionals, health plan analysts, and clinical program managers about the role of HCPCS Level II code G0121 in national preventive care workflows, common payer interactions, and what to expect when reconciling screening versus diagnostic colorectal procedures. Data not available in the input for specific modifiers, associated taxonomies, and ICD-10 pairings is noted where applicable.
Billing Code Overview
HCPCS Level II code G0121 represents colorectal cancer screening via colonoscopy for an individual not meeting criteria for high risk. The service type is colorectal cancer screening procedure (screening colonoscopy). The typical site of service is an endoscopy or hospital outpatient setting where screening colonoscopies are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old average-risk patient presents for routine colorectal cancer screening. The patient has no personal or family history of colorectal cancer, polyposis syndromes, inflammatory bowel disease, or high-risk genetic mutations. The primary care physician refers the patient for a screening colonoscopy to be performed in an outpatient endoscopy suite. Pre-procedure evaluation includes a history and physical, medication reconciliation (anticoagulant management if applicable), bowel preparation instructions, and informed consent. On the day of service, the patient receives moderate (conscious) sedation administered and monitored per facility protocol. The endoscopist performs a complete colonoscopic examination to the cecum, documents bowel prep quality, and removes or biopsies any polyps found; if no polyps or suspicious lesions are identified and no high-risk features exist, the service is billed as colorectal cancer screening colonoscopy for an individual not meeting high-risk criteria using billing code G0121. Post-procedure, recovery nursing assesses the patient until discharge criteria are met, and the endoscopist documents findings and recommended surveillance interval according to guidelines.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation component separate from the facility or technical component for diagnostic work associated with the procedure. |